Montaigu-Vendée, near Nantes, France, November 27, 2023 – Clean Cells, part of the Clean Biologics group, a provider of biopharmaceutical product quality control services and manufacturer of starting materials, today announces the launch of operations in its new production suites, located in the new facility opened in January 2023. These suites almost double Clean Cells’ portfolio of Good Manufacturing Practice (GMP) facilities. The company now has nine GMP-grade BSL2[1] laboratories, in addition to its non GMP-grade and BSL3 laboratories. With a total production area of 638 m2, the new facilities create a twofold increase in the company’s total capacity for the production and characterization of cell and virus banks.
By increasing its production capacity for starting materials, Clean Cells aims to offer its customers greater flexibility and faster project turnaround times. Cell and virus banks are the first step in any bioproduction process. They play an essential role in the development of production processes, by ensuring the safety and stability of the biological products through robust testing procedures. They also have a significant impact on the success of biopharmaceutical production projects. Thanks to its comprehensive range of services, Clean Cells can provide its customers with fast access to the biological materials they need, which, in turn, allows them to fast track their production projects. To know more
